Evidence map›Paper›PMID 42272956›Full record

ArticleBioengineering & translational medicine2026

Stealth polymer coatings of reactive oxygen species scavenging nanoparticles for immune response mitigation.

Jordyn M Wyse, Monica Prieto Nieto, Jinmin Zhang, Chia George Hsu, Marissa E Wechsler

Abstract read
In one paragraph

Article in Bioengineering & translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jordyn M WyseDepartment of Biomedical Engineering and Chemical Engineering The University of Texas at San Antonio San Antonio Texas USA.
Monica Prieto NietoDepartment of Biomedical Engineering and Chemical Engineering The University of Texas at San Antonio San Antonio Texas USA.
Jinmin ZhangDepartment of Kinesiology The University of Texas at San Antonio San Antonio Texas USA.
Chia George HsuDepartment of Kinesiology The University of Texas at San Antonio San Antonio Texas USA.
Marissa E WechslerDepartment of Biomedical Engineering and Chemical Engineering The University of Texas at San Antonio San Antonio Texas USA.ORCID https://orcid.org/0000-0003-4298-2594

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elevated levels of reactive oxygen species play an integral role in chronic inflammation. Current treatments for chronic inflammation often ignore reactive oxygen species and instead focus on symptom control or immunosuppression. However, by controlling reactive oxygen species in inflammatory environments, cyclic inflammation can be reduced. Combining reactive oxygen species scavenging delivery systems with stealth coatings can help avoid the innate immune system and enable targeted delivery to sites of inflammation without causing further oxidative stress. For this purpose, poly(propylene sulfide) nanoparticles were synthesized utilizing two different surfactants, Pluronic F-127 and sucrose monolaurate, adding stealth properties to the coatings of the reactive oxygen species scavenging nanoparticles. Characterization of the nanoparticles demonstrated the surfactant coatings did not affect the scavenging abilities nor the cytocompatibility of the materials. Degradation of the nanoparticles related to the sulfide groups and disulfide bond interactions with reactive oxygen species was also analyzed. Moreover, proinflammatory cytokine secretion from macrophages exposed to the nanoparticles was investigated to determine immune response evasion. Results obtained showed little to no activation of macrophages exposed to nanoparticle formulations in regard to MCP-1 cytokine release. However, there is room for improvement using glycerol-based coatings with regard to protecting cells from reactive oxygen species exposure and reducing macrophage activation in relation to IL-6 and TNF-alpha. Overall, the nanoparticles investigated have the capabilities to improve inflammatory disease treatments by not only targeting delivery of therapeutics to the site of inflammation, but also avoiding excess immune response recruitment due to incorporation of stealth coatings.

Indexed as

biomaterialsdrug deliveryimmunologynanoparticlesstealth polymers

Identifiers

PMID42272956
PMCPMC13247422

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.